{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:33:29Z","timestamp":1783110809593,"version":"3.54.6"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurosurgery Clinics of North America"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.nec.2025.03.006","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T11:24:52Z","timestamp":1745925892000},"page":"375-385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Thrombosis and Coagulopathy"],"prefix":"10.1016","volume":"36","author":[{"given":"Marzia","family":"Savi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Hawryluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nec.2025.03.006_bib1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3171\/jns.2002.96.1.0109","article-title":"Progressive hemorrhage after head trauma: predictors and consequences of the evolving injury","volume":"96","author":"Oertel","year":"2002","journal-title":"J Neurosurg"},{"issue":"5","key":"10.1016\/j.nec.2025.03.006_bib2","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/jcbfm.2014.31","article-title":"Translational insights into traumatic brain injury occurring during dabigatran or warfarin anticoagulation","volume":"34","author":"Schaefer","year":"2014","journal-title":"J Cerebr Blood Flow Metabol"},{"issue":"6","key":"10.1016\/j.nec.2025.03.006_bib3","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/MCC.0b013e3282f1e78f","article-title":"Acute coagulopathy of trauma: mechanism, identification and effect","volume":"13","author":"Brohi","year":"2007","journal-title":"Curr Opin Crit Care"},{"issue":"3","key":"10.1016\/j.nec.2025.03.006_bib4","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s12028-021-01400-3","article-title":"Extended coagulation profiling in isolated traumatic brain injury: a CENTER-TBI analysis","volume":"36","author":"Schaeben","year":"2022","journal-title":"Neurocritical Care"},{"issue":"5","key":"10.1016\/j.nec.2025.03.006_bib5","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1080\/10790268.2019.1708600","article-title":"Hemostatic parameters in patients with spinal cord injury in subacute and chronic phase of the rehabilitation","volume":"44","author":"Mackiewicz-Milewska","year":"2021","journal-title":"J Spinal Cord Med"},{"issue":"10","key":"10.1016\/j.nec.2025.03.006_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17100","article-title":"The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients","volume":"17","author":"Roberts","year":"2013","journal-title":"Health Technol Assess"},{"issue":"10210","key":"10.1016\/j.nec.2025.03.006_bib7","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(19)32233-0","article-title":"Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial","volume":"394","author":"Roberts","year":"2019","journal-title":"Lancet"},{"issue":"S1","key":"10.1016\/j.nec.2025.03.006_bib8","doi-asserted-by":"crossref","first-page":"S281","DOI":"10.1111\/trf.16971","article-title":"Platelet dysfunction after trauma: from mechanisms to targeted treatment","volume":"62","author":"Sloos","year":"2022","journal-title":"Transfusion (Paris)"},{"issue":"2","key":"10.1016\/j.nec.2025.03.006_bib9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/1460408620970504","article-title":"Reversal of warfarin and direct-acting oral anticoagulants in traumatic intracranial hemorrhage: four factor prothrombin complex concentrates for all?","volume":"24","author":"Moore","year":"2022","journal-title":"Trauma"},{"issue":"5","key":"10.1016\/j.nec.2025.03.006_bib10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.5858\/arpa.2014-0170-OA","article-title":"Use of thromboelastography (TEG) for detection of new oral anticoagulants","volume":"139","author":"Dias","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.nec.2025.03.006_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.991675","article-title":"The impact of direct oral anticoagulants on viscoelastic testing \u2013 a systematic review","volume":"9","author":"Sahli","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.nec.2025.03.006_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00134-020-06266-1","article-title":"Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial","volume":"47","author":"Baksaas-Aasen","year":"2021","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1016\/j.nec.2025.03.006_bib13","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/MBC.0b013e3283464f53","article-title":"The prognostic value of thrombelastography in identifying neurosurgical patients with worse prognosis","volume":"22","author":"Windel\u00f8v","year":"2011","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"3","key":"10.1016\/j.nec.2025.03.006_bib14","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.surg.2015.02.029","article-title":"Predicting progressive hemorrhagic injury from isolated traumatic brain injury and coagulation","volume":"158","author":"Folkerson","year":"2015","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.nec.2025.03.006_bib15","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s12028-022-01535-x","article-title":"Application of a TEG-platelet mapping algorithm to guide reversal of antiplatelet agents in adults with mild-to-moderate traumatic brain injury: an observational pilot study","volume":"37","author":"Kvint","year":"2022","journal-title":"Neurocritical Care"},{"issue":"9","key":"10.1016\/j.nec.2025.03.006_bib16","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1007\/s00586-013-2774-9","article-title":"Is tranexamic acid effective and safe in spinal surgery? A meta-analysis of randomized controlled trials","volume":"22","author":"Li","year":"2013","journal-title":"Eur Spine J"},{"issue":"3","key":"10.1016\/j.nec.2025.03.006_bib17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/ehjdh\/ztac046","article-title":"Systematic approach to outcome assessment from coded electronic healthcare records in the DaRe2THINK NHS-embedded randomized trial","volume":"3","author":"Wang","year":"2022","journal-title":"Eur Heart J Digital health"},{"issue":"1","key":"10.1016\/j.nec.2025.03.006_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02592271","article-title":"Age-related changes in the hemostatic system","volume":"23","author":"Abbate","year":"1993","journal-title":"Int J Clin Lab Res"},{"issue":"2","key":"10.1016\/j.nec.2025.03.006_bib19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.critrevonc.2006.06.004","article-title":"Hemostasis and aging","volume":"60","author":"Franchini","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.nec.2025.03.006_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12325-022-02333-9","article-title":"Risk and management of bleeding complications with direct oral anticoagulants in patients with atrial fibrillation and venous thromboembolism: a narrative review","volume":"40","author":"Ballestri","year":"2023","journal-title":"Adv Ther"},{"issue":"5","key":"10.1016\/j.nec.2025.03.006_bib21","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/TA.0000000000001995","article-title":"The novel oral anticoagulants (NOACs) have worse outcomes compared with warfarin in patients with intracranial hemorrhage after TBI","volume":"85","author":"Zeeshan","year":"2018","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.nec.2025.03.006_bib22","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2147\/DDDT.S94167","article-title":"Spotlight on idarucizumab and its potential for the reversal of anticoagulant effects of dabigatran","volume":"10","author":"Si\u00e9","year":"2016","journal-title":"Drug Des Dev Ther"},{"issue":"12","key":"10.1016\/j.nec.2025.03.006_bib23","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.nec.2025.03.006_bib24","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/jth.13117","article-title":"Hemodialysis for the treatment of dabigatran-associated bleeding: a case report and systematic review","volume":"13","author":"Chai-Adisaksopha","year":"2015","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.nec.2025.03.006_bib25","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.2215\/CJN.01570213","article-title":"Article extracorporeal therapy for dabigatran removal in the treatment of acute bleeding: a single center experience","volume":"8","author":"Singh","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"19","key":"10.1016\/j.nec.2025.03.006_bib26","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1056\/NEJMoa2313040","article-title":"Andexanet for factor Xa inhibitor\u2013associated acute intracerebral hemorrhage","volume":"390","author":"Connolly","year":"2024","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.nec.2025.03.006_bib27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/13696998.2022.2042106","article-title":"Cost-effectiveness of andexanet alfa versus four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-related intracranial hemorrhage in the US","volume":"25","author":"Fanikos","year":"2022","journal-title":"J Med Econ"},{"issue":"6","key":"10.1016\/j.nec.2025.03.006_bib28","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1055\/s-0041-1740180","article-title":"Andexanet alfa for specific anticoagulation reversal in patients with acute bleeding during treatment with edoxaban","volume":"122","author":"Benz","year":"2022","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.nec.2025.03.006_bib29","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/emermed-2023-213229","article-title":"Four-factor prothrombin complex concentrate versus andexanet alfa for the reversal of traumatic brain injuries","volume":"41","author":"Sadek","year":"2024","journal-title":"Emerg Med J"},{"issue":"1","key":"10.1016\/j.nec.2025.03.006_bib30","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1089\/neur.2023.0065","article-title":"Retrospective observational study of patients with subdural hematoma treated with idarucizumab","volume":"4","author":"Suehiro","year":"2023","journal-title":"Neurotrauma Rep"},{"issue":"7","key":"10.1016\/j.nec.2025.03.006_bib31","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1177\/00031348241241726","article-title":"The effect of 4-factor prothrombin complex concentrate to reverse factor Xa inhibitors in patients with traumatic intracranial hemorrhage","volume":"90","author":"Rauh","year":"2024","journal-title":"American Surgeon"},{"key":"10.1016\/j.nec.2025.03.006_bib32","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s12028-022-01521-3","article-title":"Impact of factor Xa inhibitor reversal with prothrombin complex concentrate in patients with traumatic brain injuries","volume":"37","author":"Cooksey","year":"2022","journal-title":"Neurocrit Care"},{"issue":"10","key":"10.1016\/j.nec.2025.03.006_bib33","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.ajem.2019.01.008","article-title":"Four-factor prothrombin complex concentrate for the reversal of factor Xa inhibitors for traumatic intracranial hemorrhage","volume":"37","author":"Dybdahl","year":"2019","journal-title":"Am J Emerg Med"},{"issue":"3","key":"10.1016\/j.nec.2025.03.006_bib34","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/phar.1384","article-title":"Optimizing the dose of three-factor prothrombin complex concentrate in traumatic brain injury patients on warfarin therapy","volume":"34","author":"Huynh","year":"2014","journal-title":"Pharmacotherapy"},{"issue":"11","key":"10.1016\/j.nec.2025.03.006_bib35","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.jocn.2014.05.001","article-title":"Reversal of warfarin associated coagulopathy with 4-factor prothrombin complex concentrate in traumatic brain injury and intracranial hemorrhage","volume":"21","author":"Yanamadala","year":"2014","journal-title":"Journal of Clinical Neuroscience"},{"key":"10.1016\/j.nec.2025.03.006_bib36","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jss.2017.11.008","article-title":"Activated prothrombin complex concentrate for warfarin reversal in traumatic intracranial hemorrhage","volume":"223","author":"Carothers","year":"2018","journal-title":"J Surg Res"},{"key":"10.1016\/j.nec.2025.03.006_bib37","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jss.2024.07.100","article-title":"Antiplatelet reversal is not associated with decreased progression of intracranial hemorrhage in near-isolated traumatic brain injury: a retrospective clustered analysis from two trauma centers","volume":"302","author":"Dunne","year":"2024","journal-title":"J Surg Res"},{"issue":"7","key":"10.1016\/j.nec.2025.03.006_bib38","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1007\/s10072-024-07379-x","article-title":"A multicenter study of DDAVP versus platelet transfusions for antiplatelet agent reversal in patients with traumatic brain injury","volume":"45","author":"Westfall","year":"2024","journal-title":"Neurol Sci"},{"issue":"1","key":"10.1016\/j.nec.2025.03.006_bib39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/jth.13148","article-title":"Assessment of effectiveness of major bleeding management: proposed definitions for effective hemostasis: communication from the SSC of the ISTH","volume":"14","author":"Khorsand","year":"2016","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"11","key":"10.1016\/j.nec.2025.03.006_bib40","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.40145","article-title":"Evaluation of direct oral anticoagulant reversal agents in intracranial hemorrhage: a systematic review and meta-analysis","volume":"5","author":"Chaudhary","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.nec.2025.03.006_bib41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.injury.2018.08.020","article-title":"Not all head injured patients on antiplatelet drugs need platelets: Integrating platelet reactivity testing into platelet transfusion guidelines","volume":"50","author":"Pelaez","year":"2019","journal-title":"Injury"},{"issue":"4","key":"10.1016\/j.nec.2025.03.006_bib42","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jamcollsurg.2016.06.382","article-title":"Timing of pharmacologic venous thromboembolism prophylaxis in severe traumatic brain injury: a propensity-matched cohort study","volume":"223","author":"Byrne","year":"2016","journal-title":"J Am Coll Surg"},{"issue":"2","key":"10.1016\/j.nec.2025.03.006_bib43","doi-asserted-by":"crossref","first-page":"266","DOI":"10.5853\/jos.2021.01823","article-title":"Etiology, 3-month functional outcome and recurrent events in non-traumatic intracerebral hemorrhage","volume":"24","author":"Goeldlin","year":"2022","journal-title":"J Stroke"},{"issue":"1","key":"10.1016\/j.nec.2025.03.006_bib44","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-019-2352-6","article-title":"Diagnostic and therapeutic approach in adult patients with traumatic brain injury receiving oral anticoagulant therapy: an Austrian interdisciplinary consensus statement","volume":"23","author":"Wiegele","year":"2019","journal-title":"Crit Care"},{"issue":"4","key":"10.1016\/j.nec.2025.03.006_bib45","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3171\/2021.7.SPINE21537","article-title":"Influence of severity and level of injury on the occurrence of complications during the subacute and chronic stage of traumatic spinal cord injury: a systematic review","volume":"36","author":"Adegeest","year":"2021","journal-title":"J Neurosurg Spine"},{"issue":"5","key":"10.1016\/j.nec.2025.03.006_bib46","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1097\/TA.0b013e318235ded0","article-title":"Risk of venous thromboembolism after spinal cord injury: not all levels are the same","volume":"71","author":"Maung","year":"2011","journal-title":"J Trauma Injury Infection Critical Care"},{"key":"10.1016\/j.nec.2025.03.006_bib47","first-page":"32","article-title":"V. Deep vein thrombosis prophylaxis","volume":"24","author":"Bratton","year":"2007","journal-title":"Brain Trauma Foundation Pp S"},{"issue":"Suppl.2","key":"10.1016\/j.nec.2025.03.006_bib48","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1227\/NEU.0b013e3182773549","article-title":"Introduction to the guidelines for the management of acute cervical spine and spinal cord injuries","volume":"72","author":"Hadley","year":"2013","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.nec.2025.03.006_bib49","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1310\/sci2203-209","article-title":"Prevention of venous thromboembolism in individuals with spinal cord injury: clinical practice guidelines for healthcare providers, 3rd ed.: Consortium for Spinal Cord Medicine","volume":"22","year":"2016","journal-title":"Top Spinal Cord Inj Rehabil"},{"issue":"3_supplement","key":"10.1016\/j.nec.2025.03.006_bib50","doi-asserted-by":"crossref","first-page":"84S","DOI":"10.1177\/2192568217703387","article-title":"A clinical practice guideline for the management of acute spinal cord injury: introduction, rationale, and scope","volume":"7","author":"Fehlings","year":"2017","journal-title":"Global Spine J"},{"issue":"3_supplement","key":"10.1016\/j.nec.2025.03.006_bib51","doi-asserted-by":"crossref","first-page":"138S","DOI":"10.1177\/2192568217703665","article-title":"Efficacy, safety, and timing of anticoagulant thromboprophylaxis for the prevention of venous thromboembolism in patients with acute spinal cord injury: a systematic review","volume":"7","author":"Arnold","year":"2017","journal-title":"Global Spine J"},{"issue":"7","key":"10.1016\/j.nec.2025.03.006_bib52","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sc.2014.71","article-title":"Pharmacological prophylaxis for deep vein thrombosis in acute spinal cord injury: an Indian perspective","volume":"52","author":"Halim","year":"2014","journal-title":"Spinal Cord"},{"issue":"10","key":"10.1016\/j.nec.2025.03.006_bib53","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/sc.2009.37","article-title":"Deep vein thrombosis in acute spinal cord injury","volume":"47","author":"Agarwal","year":"2009","journal-title":"Spinal Cord"},{"issue":"9","key":"10.1016\/j.nec.2025.03.006_bib54","first-page":"661","article-title":"Deep vein thrombosis: prophylaxis in acute spinal cord injured patients","volume":"69","author":"Merli","year":"1988","journal-title":"Arch Phys Med Rehabil"},{"issue":"9","key":"10.1016\/j.nec.2025.03.006_bib55","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1001\/jama.1988.03410090087036","article-title":"Fixed- vs adjusted-dose heparin in the prophylaxis of thromboembolism in spinal cord injury","volume":"260","author":"Green","year":"1988","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.nec.2025.03.006_bib56","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7326\/0003-4819-113-8-571","article-title":"Prevention of thromboembolism after spinal cord injury using low-molecular-weight heparin","volume":"113","author":"Green","year":"1990","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.nec.2025.03.006_bib57","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/sj.sc.3101298","article-title":"Primary prevention of deep venous thrombosis and pulmonary embolism in acute spinal cord injured patients","volume":"40","author":"Aito","year":"2002","journal-title":"Spinal Cord"},{"issue":"4","key":"10.1016\/j.nec.2025.03.006_bib58","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/STR.0b013e31820a8364","article-title":"Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Saposnik","year":"2011","journal-title":"Stroke"}],"container-title":["Neurosurgery Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042368025000191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042368025000191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T18:35:49Z","timestamp":1750358149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1042368025000191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1042368025000191"],"URL":"https:\/\/doi.org\/10.1016\/j.nec.2025.03.006","relation":{},"ISSN":["1042-3680"],"issn-type":[{"value":"1042-3680","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombosis and Coagulopathy","name":"articletitle","label":"Article Title"},{"value":"Neurosurgery Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nec.2025.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}